Compare · AIRJ vs TMO
AIRJ vs TMO
Side-by-side comparison of AirJoule Technologies Corporation (AIRJ) and Thermo Fisher Scientific Inc (TMO): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both AIRJ and TMO operate in Industrial Machinery/Components (Industrials), so they compete in similar markets.
- TMO is the larger of the two at $198.47B, about 683.6x AIRJ ($290.3M).
- Over the past year, AIRJ is down 10.8% and TMO is up 27.9% - TMO leads by 38.8 points.
- TMO has been more active in the news (9 items in the past 4 weeks vs 1 for AIRJ).
- TMO has more recent analyst coverage (25 ratings vs 5 for AIRJ).
- Company
- AirJoule Technologies Corporation
- Thermo Fisher Scientific Inc
- Price
- $4.03+1.51%
- $534.57+1.11%
- Market cap
- $290.3M
- $198.47B
- 1M return
- -5.62%
- +12.38%
- 1Y return
- -10.84%
- +27.92%
- Industry
- Industrial Machinery/Components
- Industrial Machinery/Components
- Exchange
- NASDAQ
- NYSE
- IPO
- 2022
- News (4w)
- 1
- 9
- Recent ratings
- 5
- 25
Thermo Fisher Scientific Inc
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; ImmunoCAP for allergy and asthma tests, and EliA for autoimmunity tests; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Services segment provides laboratory refrigerators and freezers, ultralow-temperature freezers, and cryopreservation storage tanks; temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis instruments; laboratory plastics products; laboratory chemicals; and pharma services. The company offers products and services through a direct sales force, customer-service professionals, electronic commerce, third-party distributors, and catalogs. It has a strategic alliance with the University of California, San Francisco. The company was incorporated in 1956 and is based in Waltham, Massachusetts.
Latest AIRJ
- AirJoule Technologies Unveils Prime System for Industrial-Scale Atmospheric Water Generation
- SEC Form 424B3 filed by AirJoule Technologies Corporation
- SEC Form 424B3 filed by AirJoule Technologies Corporation
- SEC Form EFFECT filed by AirJoule Technologies Corporation
- SEC Form EFFECT filed by AirJoule Technologies Corporation
- Chief Legal Officer Macdonald Chad sold $33,656 worth of shares (7,307 units at $4.61), decreasing direct ownership by 14% to 44,080 units (SEC Form 4) (tax liability)
- Chief Legal Officer Macdonald Chad converted options into 23,125 shares, increasing direct ownership by 82% to 51,387 units (SEC Form 4)
- Executive Chairman Eilers Patrick C converted options into 6,250 shares and covered exercise/tax liability with 1,832 shares, increasing direct ownership by 0.24% to 1,873,844 units (SEC Form 4)
- Chief Financial Officer Pang Stephen S. converted options into 23,125 shares and covered exercise/tax liability with 7,248 shares, increasing direct ownership by 51% to 46,937 units (SEC Form 4)
- Chief Executive Officer Jore Matthew B converted options into 12,500 shares and covered exercise/tax liability with 3,729 shares, increasing direct ownership by 0.11% to 7,748,020 units (SEC Form 4)
Latest TMO
- Thermo Fisher Scientific Announces Quarterly Dividend
- Thermo Fisher Scientific to Hold Earnings Conference Call on Thursday, July 23, 2026
- SEC Form 4 filed by Director Sperling Scott M
- SEC Form 4 filed by Director Keith R. Alexandra
- SEC Form 4 filed by Director Weisler Dion J
- SEC Form 4 filed by Director Lynch Karen S
- SEC Form 4 filed by Director Johnson Jennifer M
- Bernstein resumed coverage on Thermo Fisher with a new price target
- SEC Form 11-K filed by Thermo Fisher Scientific Inc
- Piper Sandler initiated coverage on Thermo Fisher with a new price target